Cite

HARVARD Citation

    Udell, J. et al. (2020). Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL Study. Endocrinology, diabetes & metabolism. 3 (1), p. n/a. [Online]. 
  
Back to record